MIMEDX GROUP, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.25 USD | -0.32% |
|
-1.73% | -28.73% |
| Mar. 27 | MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products | MT |
| Mar. 27 | MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit | DJ |
- Stock Market
- Equities
- MDXG Stock
- News MiMedx Group, Inc.
- MarketScreener Strategies
